ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)

ClinicalTrials.gov ID: NCT01300013

Public ClinicalTrials.gov record NCT01300013. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 12:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure

Study identification

NCT ID
NCT01300013
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cytokinetics
Industry
Enrollment
614 participants

Conditions and interventions

Conditions

Interventions

  • Omecamtiv mecarbil Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2011
Primary completion
Mar 31, 2013
Completion
Aug 31, 2013
Last update posted
Jul 26, 2021

2011 – 2013

United States locations

U.S. sites
45
U.S. states
22
U.S. cities
41
Facility City State ZIP Site status
Research Site Mobile Alabama 36608
Research Site Inglewood California 90301
Research Site La Jolla California 92037
Research Site San Francisco California 94121
Research Site Danbury Connecticut 06810
Research Site Newark Delaware 19718
Research Site Atlantis Florida 33462
Research Site Clearwater Florida 33756
Research Site Fort Lauderdale Florida 33308
Research Site Miami Florida 33133
Research Site Orlando Florida 32803
Research Site Atlanta Georgia 30322
Research Site Chicago Illinois 60611
Research Site Peoria Illinois 61636
Research Site Baltimore Maryland 21201
Research Site Detroit Michigan 48201
Research Site Detroit Michigan 48202
Research Site Novi Michigan 48374
Research Site Minneapolis Minnesota 55417
Research Site St Louis Missouri 63110
Research Site Lincoln Nebraska 68506
Research Site Newark New Jersey 07103
Research Site Cortlandt Manor New York 10567
Research Site Roslyn New York 11576
Research Site The Bronx New York 10467
Research Site Chapel Hill North Carolina 27599
Research Site Charlotte North Carolina 28204
Research Site Durham North Carolina 27705
Research Site Winston-Salem North Carolina 27103
Research Site Cincinnati Ohio 45219
Research Site Cincinnati Ohio 45220
Research Site Cincinnati Ohio 45267
Research Site Cleveland Ohio 44109
Research Site Columbus Ohio 43210
Research Site Fairfield Ohio 45014
Research Site Oklahoma City Oklahoma 73120
Research Site Portland Oregon 97239
Research Site Charleston South Carolina 29425
Research Site Greenville South Carolina 29605
Research Site Memphis Tennessee 38120
Research Site Nashville Tennessee 37203
Research Site Nashville Tennessee 37232-8802
Research Site Tullahoma Tennessee 37388
Research Site Houston Texas 77030
Research Site Murray Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 105 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01300013, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2021 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01300013 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →